Solicitation of Nominations for Appointment to the Clinical Laboratory Improvement Advisory Committee (CLIAC), 55887 [2018-24461]

Download as PDF Federal Register / Vol. 83, No. 217 / Thursday, November 8, 2018 / Notices October 5, 2018 Volume 83, Number 194, page 50378. The call-in number and passcode should read as follows: call-in number, 866–803–2146, passcode: 80256461. FOR FURTHER INFORMATION CONTACT: Erin Stone, M.A., HICPAC, Division of Healthcare Quality Promotion, NCEZID, CDC, 1600 Clifton Road NE, Mailstop A–07, Atlanta, Georgia 30329–4027; Email: HICPAC@cdc.gov. The Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Sherri Berger, Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2018–24463 Filed 11–7–18; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Solicitation of Nominations for Appointment to the Clinical Laboratory Improvement Advisory Committee (CLIAC) ACTION: Notice. The Centers for Disease Control and Prevention (CDC) is seeking nominations for membership on the CLIAC. The CLIAC, consists of 20 experts including the Chair in the fields associated with microbiology (including bacteriology, mycobacteriology, mycology, parasitology, and virology), immunology (including histocompatibility), chemistry, hematology, pathology (including histopathology and cytology), genetic testing (including cytogenetics); from representatives in the fields of medical technology, public health, and clinical practice; and from consumer representatives. Nominations are being sought for individuals who have expertise and qualifications necessary to contribute to the accomplishments of the committee’s objectives. Nominees will be selected based on expertise in the fields of microbiology (including bacteriology, mycobacteriology, mycology, parasitology, and virology), immunology (including histocompatibility), chemistry, hematology, pathology (including histopathology and cytology), daltland on DSKBBV9HB2PROD with NOTICES SUMMARY: VerDate Sep<11>2014 16:51 Nov 07, 2018 Jkt 247001 or genetic testing (including cytogenetics); from representatives in the fields of medical technology, public health, and clinical practice; and from consumer representatives. Members may be invited to serve for up to fouryear terms. Selection of members is based on candidates’ qualifications to contribute to the accomplishment of CLIAC objectives (https://www.cdc.gov/cliac/). DATES: Nominations for membership on the CLIAC must be received no later than May 1, 2019. Packages received after this time will not be considered for the current membership cycle. ADDRESSES: All nominations should be mailed to Nancy Anderson, MMSc, MT(ASCP), CLIAC Secretary, Senior Advisor for Clinical Laboratories, Division of Laboratory Systems, Center for Surveillance, Epidemiology and Laboratory Services, Office of Public Health Scientific Services, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Mailstop V24–3, Atlanta, Georgia 30329–4018; telephone (404) 498–2741; or via email at NAnderson@cdc.gov or faxed to (404) 471–2706. FOR FURTHER INFORMATION CONTACT: Heather Stang, MS, Deputy Branch Chief, Quality and Safety Systems Branch, Division of Laboratory Systems, Center for Surveillance, Epidemiology and Laboratory Services, Office of Public Health Scientific Services, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Mailstop V24–3, Atlanta, Georgia 30329–4018; telephone (404) 498–2769; HStang@cdc.gov. SUPPLEMENTARY INFORMATION: The U.S. Department of Health and Human Services policy stipulates that committee membership be balanced in terms of points of view represented, and the committee’s function. Appointments shall be made without discrimination on the basis of age, race, ethnicity, gender, sexual orientation, gender identity, HIV status, disability, and cultural, religious, or socioeconomic status. Nominees must be U.S. citizens. Current participation on federal workgroups or prior experience serving on a federal advisory committee does not disqualify a candidate; however, HHS policy is to avoid excessive individual service on advisory committees and multiple committee memberships. Committee members are Special Government Employees (SGEs), requiring the filing of financial disclosure reports at the beginning and annually during their terms. CDC reviews potential candidates for CLIAC membership each year, and provides a PO 00000 Frm 00037 Fmt 4703 Sfmt 4703 55887 slate of nominees for consideration to the Secretary of HHS for final selection. HHS notifies selected candidates of their appointment near the start of the term in July, or as soon as the HHS selection process is completed. Note that the need for different expertise varies from year to year and a candidate who is not selected in one year may be reconsidered in a subsequent year. SGE Nominees must be U.S. citizens. Candidates should submit the following items: D Current curriculum vitae, including complete contact information (telephone numbers, mailing address, email address) D At least one letter of recommendation from person(s) not employed by the U.S. Department of Health and Human Services. (Candidates may submit letter(s) from current HHS employees if they wish, but at least one letter must be submitted by a person not employed by an HHS agency (e.g., CDC, NIH, FDA, etc.). Nominations may be submitted by the candidate him- or herself, or by the person/organization recommending the candidate. The Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both CDC and the Agency for Toxic Substances and Disease Registry. Sherri Berger, Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2018–24461 Filed 11–7–18; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [Docket Number CDC–2018–0103, NIOSH– 322] Draft—National Occupational Research Agenda for Immune, Infectious and Dermal Disease Prevention (IID) National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Request for comment. AGENCY: The National Institute for Occupational Safety and Health of the Centers for Disease Control and Prevention announces the availability of SUMMARY: E:\FR\FM\08NON1.SGM 08NON1

Agencies

[Federal Register Volume 83, Number 217 (Thursday, November 8, 2018)]
[Notices]
[Page 55887]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-24461]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Solicitation of Nominations for Appointment to the Clinical 
Laboratory Improvement Advisory Committee (CLIAC)

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC) is 
seeking nominations for membership on the CLIAC. The CLIAC, consists of 
20 experts including the Chair in the fields associated with 
microbiology (including bacteriology, mycobacteriology, mycology, 
parasitology, and virology), immunology (including histocompatibility), 
chemistry, hematology, pathology (including histopathology and 
cytology), genetic testing (including cytogenetics); from 
representatives in the fields of medical technology, public health, and 
clinical practice; and from consumer representatives.
    Nominations are being sought for individuals who have expertise and 
qualifications necessary to contribute to the accomplishments of the 
committee's objectives. Nominees will be selected based on expertise in 
the fields of microbiology (including bacteriology, mycobacteriology, 
mycology, parasitology, and virology), immunology (including 
histocompatibility), chemistry, hematology, pathology (including 
histopathology and cytology), or genetic testing (including 
cytogenetics); from representatives in the fields of medical 
technology, public health, and clinical practice; and from consumer 
representatives. Members may be invited to serve for up to four-year 
terms.
    Selection of members is based on candidates' qualifications to 
contribute to the accomplishment of CLIAC objectives (https://www.cdc.gov/cliac/).

DATES: Nominations for membership on the CLIAC must be received no 
later than May 1, 2019. Packages received after this time will not be 
considered for the current membership cycle.

ADDRESSES: All nominations should be mailed to Nancy Anderson, MMSc, 
MT(ASCP), CLIAC Secretary, Senior Advisor for Clinical Laboratories, 
Division of Laboratory Systems, Center for Surveillance, Epidemiology 
and Laboratory Services, Office of Public Health Scientific Services, 
Centers for Disease Control and Prevention, 1600 Clifton Road NE, 
Mailstop V24-3, Atlanta, Georgia 30329-4018; telephone (404) 498-2741; 
or via email at [email protected] or faxed to (404) 471-2706.

FOR FURTHER INFORMATION CONTACT: Heather Stang, MS, Deputy Branch 
Chief, Quality and Safety Systems Branch, Division of Laboratory 
Systems, Center for Surveillance, Epidemiology and Laboratory Services, 
Office of Public Health Scientific Services, Centers for Disease 
Control and Prevention, 1600 Clifton Road NE, Mailstop V24-3, Atlanta, 
Georgia 30329-4018; telephone (404) 498-2769; [email protected].

SUPPLEMENTARY INFORMATION: The U.S. Department of Health and Human 
Services policy stipulates that committee membership be balanced in 
terms of points of view represented, and the committee's function. 
Appointments shall be made without discrimination on the basis of age, 
race, ethnicity, gender, sexual orientation, gender identity, HIV 
status, disability, and cultural, religious, or socioeconomic status. 
Nominees must be U.S. citizens. Current participation on federal 
workgroups or prior experience serving on a federal advisory committee 
does not disqualify a candidate; however, HHS policy is to avoid 
excessive individual service on advisory committees and multiple 
committee memberships. Committee members are Special Government 
Employees (SGEs), requiring the filing of financial disclosure reports 
at the beginning and annually during their terms. CDC reviews potential 
candidates for CLIAC membership each year, and provides a slate of 
nominees for consideration to the Secretary of HHS for final selection. 
HHS notifies selected candidates of their appointment near the start of 
the term in July, or as soon as the HHS selection process is completed. 
Note that the need for different expertise varies from year to year and 
a candidate who is not selected in one year may be reconsidered in a 
subsequent year. SGE Nominees must be U.S. citizens. Candidates should 
submit the following items:
    [ssquf] Current curriculum vitae, including complete contact 
information (telephone numbers, mailing address, email address)
    [ssquf] At least one letter of recommendation from person(s) not 
employed by the U.S. Department of Health and Human Services. 
(Candidates may submit letter(s) from current HHS employees if they 
wish, but at least one letter must be submitted by a person not 
employed by an HHS agency (e.g., CDC, NIH, FDA, etc.).
    Nominations may be submitted by the candidate him- or herself, or 
by the person/organization recommending the candidate.
    The Chief Operating Officer, Centers for Disease Control and 
Prevention, has been delegated the authority to sign Federal Register 
notices pertaining to announcements of meetings and other committee 
management activities for both CDC and the Agency for Toxic Substances 
and Disease Registry.

Sherri Berger,
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2018-24461 Filed 11-7-18; 8:45 am]
 BILLING CODE 4163-18-P